COMMUNIQUÉS West-GlobeNewswire

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
12/02/2025
The Company will Host a Conference Call and Webcast on February 27, 2025, at 8:30 AM ET CORAL GABLES, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a [...]
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
11/02/2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that [...]
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
11/02/2025
ROCKVILLE, Md., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Precision Optics Schedules Second Quarter of Fiscal Year 2025 Conference Call for February 13, 2025
11/02/2025
GARDNER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
11/02/2025
WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the [...]
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
11/02/2025
ALISO VIEJO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced [...]
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
11/02/2025
-- Targeting Unmet Needs for Treating Solid Tumors-- REDWOOD CITY, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration [...]
Regeneron Announces Investor Conference Presentations
11/02/2025
TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) will webcast management participation as follows: TD Cowen 45 th Annual Health Care Conference at 11:50 a.m. ET on [...]
Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
11/02/2025
SUNNYVALE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
11/02/2025
SEATTLE, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]
Bicara Therapeutics Announces First Patients Enrolled in FORTIFI-HN01, a Pivotal Phase 2/3 Clinical Trial of Ficerafusp Alfa in 1L Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
11/02/2025
BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
11/02/2025
-2025 is poised to be a catalyst-rich year with key updates across several programs- -Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in [...]
Marius Pharmaceuticals Announces KYZATREX® (testosterone undecanoate) CIII Capsules Availability Through Thrive, Expanding Men's Health Solutions
11/02/2025
RALEIGH, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals is pleased to announce that Thrive , a leading provider of personalized healthcare solutions and a trusted partner of O2 Fitness, now offers [...]
SportGait and Heads Together Health Merge to Form NeuroTech Insights, Transforming Neurofunctional Prehabilitation, Performance, and Recovery
11/02/2025
RALEIGH, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- SportGait, a leading innovator in prehabilitation, performance, and recovery solutions, proudly announces its merger with Branelie Health, Inc., operating as Heads [...]
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®
11/02/2025
WASHINGTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical company today announced that the United States Food and Drug [...]
IBA - Information réglementée
11/02/2025
Le 11 février 2025, 18h00 En vertu de cette disposition : « [...] l'émetteur publie le total du capital, le nombre total de titres conférant le droit de vote et de droits de vote, ainsi que, par catégorie, le nombre de [...]
IBA - Regulated Information
11/02/2025
IBA SA – Section 15 of the transparency act February 11 th 6:00, 2025 Publication made under article 15 of the law of May 2, 2007 relating to the disclosure of major holdings in issuers whose shares are admitted to [...]
IBA – Transparency Notification IBA SA
11/02/2025
IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 11th, 2025 06:00 Summary of the notification IBA (Ion Beam [...]
IBA - PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE IBA SA
11/02/2025
IBA SA – NOTIFICATION TRANSPARENCE (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 11 février 2025, 18h Résumé de la notification [...]

Pages